Antimicrobial bacteriostatic agent,
sulfanilamide. The mechanism of action of the drug due to competitive antagonism with para-aminobenzoic acid (PABA), inhibition digidropteroatsintazy, tetrahydrofolic acid synthesis disorder necessary for the synthesis of purines and pyrimidines. It is active against Staphylococcus spp., Streptococcus spp., Including S.pyogenes, S.pneumoniae, Legionella spp., Brucella spp., Escherichia coli, Shigella spp., Klebsiella spp., Proteus spp., Salmonella spp., Serratia spp., Calymmatobactcrium granulomatis, Vibrio cholerae, Clostridium perfringens, Bacillus anthracis, Nocardia asteroids, Corynebacterium diphtheriae, Yersinia pestis, Chlamydia spp., Actinomyces israelii, Toxoplasma gondii.
When applied to the skin, it contributes to the rapid healing of wounds and epithelialization of erosion.